BRPI0817334A2 - Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados - Google Patents

Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados

Info

Publication number
BRPI0817334A2
BRPI0817334A2 BRPI0817334A BRPI0817334A2 BR PI0817334 A2 BRPI0817334 A2 BR PI0817334A2 BR PI0817334 A BRPI0817334 A BR PI0817334A BR PI0817334 A2 BRPI0817334 A2 BR PI0817334A2
Authority
BR
Brazil
Prior art keywords
mycoplasma gallisepticum
composition
attenuated mycoplasma
clones
identifying
Prior art date
Application number
Other languages
English (en)
Inventor
Mahesh Kumar
Muhammad Ayub Khan
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI0817334A2 publication Critical patent/BRPI0817334A2/pt
Publication of BRPI0817334A8 publication Critical patent/BRPI0817334A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0817334A 2007-09-11 2008-09-10 Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados BRPI0817334A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99344707P 2007-09-11 2007-09-11
PCT/US2008/010630 WO2009035644A1 (en) 2007-09-11 2008-09-10 Attenuated mycoplasma gallisepticum strains

Publications (2)

Publication Number Publication Date
BRPI0817334A2 true BRPI0817334A2 (pt) 2015-03-24
BRPI0817334A8 BRPI0817334A8 (pt) 2016-03-29

Family

ID=40024216

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817334A BRPI0817334A8 (pt) 2007-09-11 2008-09-10 Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados

Country Status (21)

Country Link
US (4) US7935356B2 (pt)
EP (2) EP2564868A1 (pt)
JP (2) JP5451619B2 (pt)
KR (2) KR20120014041A (pt)
CN (1) CN101896195B (pt)
AR (1) AR068418A1 (pt)
AU (1) AU2008299913B2 (pt)
BR (1) BRPI0817334A8 (pt)
CA (1) CA2699410C (pt)
CL (1) CL2008002675A1 (pt)
CO (1) CO6260102A2 (pt)
ES (1) ES2437593T3 (pt)
ME (1) ME00982B (pt)
MX (1) MX2010002866A (pt)
NZ (1) NZ583829A (pt)
PL (1) PL2200640T3 (pt)
RU (1) RU2441909C2 (pt)
TW (1) TW200918666A (pt)
UA (1) UA98506C2 (pt)
WO (1) WO2009035644A1 (pt)
ZA (1) ZA201001740B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068231A1 (en) * 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
EP2571980A4 (en) * 2010-05-19 2014-02-26 Bioproperties Pty Ltd METHOD RELATED TO A WEAKEN MYCOPLASMA
CN102168073B (zh) * 2010-11-30 2013-03-20 瑞普（保定）生物药业有限公司 一种提高疫苗生产中鸡毒支原体增殖能力的方法
CN103074246B (zh) * 2012-08-31 2015-09-02 南京天邦生物科技有限公司 一种低血清高效培养鸡毒支原体弱毒株培养基及其制备方法
CN107446859B (zh) * 2017-09-02 2020-12-18 河南省农业科学院畜牧兽医研究所 一株鸡毒支原体及其应用
CN112159479B (zh) * 2020-10-15 2022-03-22 福建农林大学 一种鸡毒支原体多抗原表位融合蛋白pMG-mEA及其应用
CN114045298B (zh) * 2021-09-09 2023-10-20 武汉科前生物股份有限公司 一种鸡滑液囊支原体亚单位疫苗及制备方法及应用
CN114973312A (zh) * 2022-04-28 2022-08-30 广西宏廷智能科技有限公司 一种滑液囊支原体感染的智能化检测方法及系统
CN114940955B (zh) * 2022-05-10 2023-08-11 兆丰华生物科技(南京)有限公司 一种鸡毒支原体弱毒疫苗株及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566833B1 (fr) * 1984-06-27 1986-11-14 Inst Francais Du Petrole Methode et perfectionnement aux outils de forage comportant des passages d'eau permettant une grande efficacite du nettoyage du front de taille
ES2058237T3 (es) * 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
US6006134A (en) * 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US7599736B2 (en) * 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
ATE417932T1 (de) * 1999-06-22 2009-01-15 Korea Kumho Petrochem Co Ltd Farnesylpyrophosphat-synthase (fps) aus setzlingen der sonnenblume (helianthus annus)
JP4723707B2 (ja) * 1999-12-22 2011-07-13 パナソニック電工株式会社 痩身器具
US6885888B2 (en) * 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
US6922590B1 (en) * 2000-11-21 2005-07-26 Advanced Bionics Corporation Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
US6721603B2 (en) * 2002-01-25 2004-04-13 Cyberonics, Inc. Nerve stimulation as a treatment for pain
US7551964B2 (en) * 2002-03-22 2009-06-23 Leptos Biomedical, Inc. Splanchnic nerve stimulation for treatment of obesity
US7239912B2 (en) * 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US7076292B2 (en) * 2002-04-25 2006-07-11 Medtronic, Inc. Optical communication of neurostimulation-system information
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US7155278B2 (en) * 2003-04-21 2006-12-26 Medtronic, Inc. Neurostimulation to treat effects of sleep apnea
KR101131845B1 (ko) * 2003-07-25 2012-03-30 베링거잉겔하임베트메디카인코퍼레이티드 유럽 기원의 로소니아 인트라셀룰라리스, 및 이의 백신,진단제 및 사용 방법
TW200918666A (en) * 2007-09-11 2009-05-01 Wyeth Corp Attenuated mycoplasma gallisepticum strains

Also Published As

Publication number Publication date
RU2441909C2 (ru) 2012-02-10
AU2008299913A1 (en) 2009-03-19
EP2200640B1 (en) 2013-10-23
JP2010538646A (ja) 2010-12-16
EP2564868A1 (en) 2013-03-06
ES2437593T3 (es) 2014-01-13
HK1145627A1 (en) 2011-04-29
UA98506C2 (en) 2012-05-25
ZA201001740B (en) 2014-03-26
US20110189099A1 (en) 2011-08-04
CN101896195B (zh) 2013-04-03
PL2200640T3 (pl) 2014-02-28
CA2699410A1 (en) 2009-03-19
JP2014027950A (ja) 2014-02-13
CN101896195A (zh) 2010-11-24
AR068418A1 (es) 2009-11-18
KR20120014041A (ko) 2012-02-15
BRPI0817334A8 (pt) 2016-03-29
JP5451619B2 (ja) 2014-03-26
CL2008002675A1 (es) 2008-11-07
EP2200640A1 (en) 2010-06-30
CO6260102A2 (es) 2011-03-22
US20130302373A1 (en) 2013-11-14
US8298552B2 (en) 2012-10-30
US20090068232A1 (en) 2009-03-12
ME00982B (me) 2011-04-30
US7935356B2 (en) 2011-05-03
MX2010002866A (es) 2010-04-01
CA2699410C (en) 2013-08-20
NZ583829A (en) 2011-12-22
TW200918666A (en) 2009-05-01
RU2010108641A (ru) 2011-10-20
KR20100061526A (ko) 2010-06-07
US20130022547A1 (en) 2013-01-24
AU2008299913B2 (en) 2014-05-08
KR101176717B1 (ko) 2012-09-03
WO2009035644A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
BRPI0817334A2 (pt) Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados
BRPI0820341A2 (pt) bactéria mycoplasma viva, atenuada, composição de vacina e métodod para identificar clones de mycoplasma atenuados
BRPI0907438A2 (pt) Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
BRPI0915696A2 (pt) vacina de rotavírus estável, secada, composições e processo para preparação da mesma
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
DK2291195T4 (da) Vaccine til beskyttelse mod lawsonia intracellularis, mycoplasma hyopneumoniae og porcin circovirus
BRPI0815841A2 (pt) Métodos e composições para melhoramento de traços preferidos.
BRPI1012213A2 (pt) "solventes e composições para tratamento de formações contendo hidrocarboneto"
BRPI0815457A2 (pt) "composição com base em tereftalato de politrimetileno, processo para preparar composição com base em tereftalato de politrimetileno e artigo"
BRPI0813307A2 (pt) Composição imunogênica, vacina, e, processo para fabricar a vacina
BRPI0920955A2 (pt) processo para a preparação de uma composição polimérica , composição polimérica, misturas, e, uso da composição polimérica
BRPI0909820A2 (pt) Processo para estabilização de composição de vacina contra gripe, para estabilização de composição de vacina contendo adjuvante e para preparação de vacina, composições de vacina, kit de vacina e método de estocagem de uma matéria prima
ES2743029T8 (es) Composiciones de extremo del transposón y métodos para modificar ácidos nucleicos
BRPI0918972A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso
EP1991262A4 (en) MYCOPLASMA HYOPNEUMONIAE VACCINE
BRPI0914343A2 (pt) composição, produto, uso da composição e método
UY32570A (es) Vacuna viva modificada de mycoplasma bovis mejorada
BRPI0919642A2 (pt) composição para cuidados domésticos, utilização de um nanogel catiônico e processo de realização de cuidados domésticos.
BRPI0910963A2 (pt) composição imunogênica, método para tratar ou prevenir doença pneumocócica, e , uso de uma composição imunogênica
DK2200430T3 (da) Sammensætning indeholdende p-menthan-3,8-diol og dets anvendelse som insektreppellant
SG10201506597RA (en) Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
BRPI0921399A2 (pt) composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante
BRPI0807597A2 (pt) Composição farmacêutica, e, método para tratar infecção por vírus da influenza
BRPI0912045A2 (pt) polisilano halogenado e processo térmico para sua preparação
BRPI0920862A2 (pt) composição, método para fabricação da mesma, e uso da mesma

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PAH W LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS W LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements